Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults
Clinical trial NCT02071082 · COMPLETED
Trial details
- NCT number
- NCT02071082
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-25
- Primary completion
- 2015-01-23
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.